Rhythm Pharmaceuticals Sponsors Second Annual International Meeting on Pathway-Related Obesity: Vision & Evidence (IMPROVE) 2023

December 15, 2023

https://www.globenewswire.com/news-release/2023/12/13/2795424/0/en/Rhythm-Pharmaceuticals-Sponsors-Second-Annual-International-Meeting-on-Pathway-Related-Obesity-Vision-Evidence-IMPROVE-2023.html

— More than 50 poster presentations highlighting new scientific developments to advance the care of people living with rare MC4R pathway diseases —

— Approximately 150 healthcare professionals from 20 countries expected to attend —

Read more at globenewswire.com

Related news for (RYTM)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.